
British Society for Immunology
BSI on MedicMessImmunotherapy Advances
In PubMed through PubMed Central. Fully open access. Published by Oxford University Press for the British Society for Immunology.
Publishing in Immunotherapy Advances
Immunotherapy Advances is an open access journal of the British Society for Immunology. It publishes work on interventions that change immune responses across human and animal diseases, from discovery research and preclinical models to clinical studies. Research Articles present new findings; Reviews summarise published evidence; Commentaries discuss published work; Clinical Trial Protocols describe planned trials. Historical Perspectives are invitation only. The journal welcomes studies that connect immunology with engineering and other physical sciences.
There is no general fee-free publication route. The standard open access charge is £2,540 before tax, with society member discounts, country waivers and possible institutional funding. Reviews require a pre-submission enquiry, and the journal does not consider protocols for systematic reviews or meta-analyses. It uses single-anonymised review by at least two independent experts. Its 2025 median time from submission to first decision was about 41 days.
Free subscriber access
Free with a subscription: the author guide in one place
Word limits, abstract lengths and fees for each article type, and a checklist before you submit. Enter your email to unlock this journal and every other guide.
You'll also receive The Weekend Round every Saturday.- Research Article
New experimental findings or conceptual analyses; a graphical abstract is required.
- Words
- 8,000
- Abstract
- 250
- Figures & tables
- 12
- References
- 50
- Reviews
A synthesis of published work; send a pre-submission enquiry first.
- Words
- 5,000
- Abstract
- 250
- Figures & tables
- 12
- References
- 100
- Commentary
Evidence-based discussion of a published article; cite the original work in the paper and cover letter.
- Words
- 1,500
- Abstract
- 150
- Figures & tables
- 4
- References
- 15
- Clinical Trial Protocols
Prospectively registered trial plans; systematic review protocols are excluded.
- Words
- 4,000
- Abstract
- 250
- Figures & tables
- 16
- References
- 100
- Historical Perspective
An invitation-only account of an early immunology discovery; authors may enquire before submission.
- Words
- —
- Abstract
- —
- Figures & tables
- —
- References
- —
The standard charge is £2,540 before applicable tax for each category in the journal's calculator. British Society for Immunology members receive 20% off and Canadian Society for Immunology members receive 15% off. Eligible countries receive discounts or waivers; some institutional agreements cover the charge, and discretionary waivers are available.
Before you submit
- Send a pre-submission enquiry before preparing a Review.
- Register clinical trials prospectively and include the registry, registration number and funding status in a protocol.
- Include a Data Availability Statement and cite public datasets with a persistent identifier.
- Provide the submitting author's ORCID iD and disclose AI use in the cover letter and manuscript.
- Add alt text beneath each figure legend, and provide a graphical abstract for a Research Article.
- Use an institutional email address where possible, or explain its absence in the cover letter.
Present it first.
Similar journals.
Frequently asked
- Is Immunotherapy Advances indexed in PubMed?
- Yes, through PubMed Central. Its articles are deposited in PMC and appear in PubMed with a PMID; it is not indexed in MEDLINE.
- How much does it cost to publish in Immunotherapy Advances?
- The article processing charge is £2,540.
- Does Immunotherapy Advances accept case reports?
- No. Immunotherapy Advances does not publish case reports.
- What is the Impact Factor of Immunotherapy Advances?
- Immunotherapy Advances states an Impact Factor of 4.4 for 2025.
- How long does Immunotherapy Advances take to decide?
- About 41 days from submission to first decision.
- What kind of peer review does Immunotherapy Advances use?
- Single-blind peer review.
PubMed via PMC · APC £2,540 · First decision in 41 days
- Accepted work
- Original research · Literature review
- Acceptance rate
- Not stated
- Peer review
- Single-blind
- Access
- Free to read
Checked against the journal’s author guide · updated 14 Oct 2026

